EMMYON

Emmyon is a biotechnology company. We investigate how aging, illness and injury cause muscle atrophy. We then use those data to discover small molecules that improve muscle strength, mass and metabolism. Some of our small molecules are being used to create new food products for muscle health, and others are being developed as medicines for muscle atrophy, obesity and type 2 diabetes... Emmyon, Inc. is a privately-held biotechnology corporation. Our expertise is in skeletal muscle biology, metabolism, and small molecule discovery. Our business model is to discover small molecules with beneficial effects for human and animal health, and then commercialize those molecules via out-licensing agreements with consumer-facing companies. We are also involved in R&D collaborations with our commercialization partners... Emmyon's portfolio of patent-protected technology includes natural dietary compounds such as ursolic acid and tomatidine, as well as novel compounds. Our natural compounds are..

Also known as: Emmyon, Inc.